How to Buy Mereo Biopharma Group Stock
Mereo Biopharma Group PLC
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally.
Mereo Biopharma Group stock last closed at $1.96, up 12% from the previous day, and has decreased 44.79% in one year. It has overperformed other stocks in the Biotechnology industry by 0.05 percentage points. Mereo Biopharma Group stock is currently +33.33% from its 52-week low of $1.47, and -50.25% from its 52-week high of $3.94.
There are currently 795.66M MREO shares outstanding. The market cap of MREO is $311.90M. In the past 24 hours, 11.64M MREO shares were traded.
How to Buy Mereo Biopharma Group Stock
Wondering how to invest in Mereo Biopharma Group stock? Here's how.
- Choose where to buy Mereo Biopharma Group stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Mereo Biopharma Group stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Evaluate Mereo Biopharma Group stock: The Mereo Biopharma Group ticker symbol is MREO. Is Mereo Biopharma Group stock a good investment? Should you buy shares of MREO? How do MREO's underlying business fundamentals look? Do top analysts think Mereo Biopharma Group is a good buy? Why has MREO's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if MREO is a good stock to buy).
- Execute your MREO trade: Decide if you will purchase MREO shares at the current market price or use a limit order to purchase MREO shares at a specific price.
- Watch your investment in MREO: Create a watchlist to get the latest news on your new investment in Mereo Biopharma Group stock.
Step 1: Choose where to buy Mereo Biopharma Group stock
You will need a brokerage account in order to access the NASDAQ market and buy MREO shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can buy MREO today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the best stock market app, you need to deposit funds:
Watch the video below for more details depositing money into your new investment account.
Step 4: Evaluate Mereo Biopharma Group stock
After you have decided on the best place to buy Mereo Biopharma Group stock, it's absolutely critical to evaluate their stock prior to investing, so you can understand the risk as well as the upside.
Mereo Biopharma Group quick stats
Mereo Biopharma Group Due Diligence Checks
WallStreetZen was designed to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on MREO's stock page.
Is MREO stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MREO's fair value.
Using relative valuations metrics:
- MREO may be overvalued based on its P/B ratio of 6.69x, relative to Biotechnology industry P/B ratio of 5.27x
You can do additional valuation research on MREO's stock here.
A look at MREO Cashflows and Balance Sheet
Signs that MREO is financially healthy:
- MREO has a low debt to equity ratio of 0.15.
- There are more short-term assets than short-term liabilities on the MREO balance sheet.
- MREO has $48.70M in cash and short term investments. This is enough to cover its annual cash burn of $32.73M.
- MREO has cash burn of 32729000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the MREO balance sheet.
Signs that MREO is not financially healthy:
- MREO profit margin has gone down from -4,531.6% to -8,314.6% in the past year.
Is it a good time to buy MREO stock, according to Wall Street analysts?
Out of 2 Wall Street analysts who give recommendations on MREO, the consensus analyst rating on Mereo Biopharma Group is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Mereo Biopharma Group stock forecast page.
MREO Technicals
MREO Performance Metrics
Last year, MREO revenue was $500.00k. Over the past one years, MREO's revenue has gone up by -50% per year. This was slower than the Biotechnology industry average of 43.81%.
Find out more about MREO's earnings and revenue performance here.
Latest Insiders Trades at MREO
Over the past year, executives and large shareholders at MREO have not bought or sold any shares.
Dig into more about who owns MREO stock here.
Can I rely on MREO as an income stream?
No, Mereo Biopharma Group doesn't provide an income stream by paying out dividends.
What do other investors have to say about MREO?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your MREO trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you want more assistance buying stocks on eToro, watch the helpful video below:
Step 6: Watch your investment in MREO
Now that you own some MREO shares, you'll want to keep up with your new stock purchase.
Add MREO to a watchlist to get the latest updates about your MREO stock.
MREO Feed
How to Buy Stock in Mereo Biopharma Group
To reiterate, here are the 6 steps to buy stock in Mereo Biopharma Group:
- Choose where to buy Mereo Biopharma Group stock
- Create your brokerage account
- Deposit funds into your investment account
- Evaluate Mereo Biopharma Group stock
- Execute your MREO trade
- Watch your investment in MREO
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Mereo Biopharma Group, create a watchlist on WallStreetZen today.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.